Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells

Tumor angiogenesis is widely recognized as one of the “hallmarks of cancer”. Consequently, during the last decades the development and testing of commercial angiogenic inhibitors has been a central focus for both basic and clinical cancer research. While antiangiogenic drugs are now incorporated int...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Mauricio P., Sotomayor, Paula, Carrasco-Avino, Gonzalo, Corvalan, Alejandro H., Owen, Gareth I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037767/
https://www.ncbi.nlm.nih.gov/pubmed/27608016
http://dx.doi.org/10.3390/ijms17091489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037767/
https://www.ncbi.nlm.nih.gov/pubmed/27608016
http://dx.doi.org/10.3390/ijms17091489

Ejemplares similares